Impact of Endoscopic Bronchial Ultrasound (EBUS) on Outcomes for Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Hypofractionated Radiotherapy (HFRT)

The following study retrospectively reviewed 92 clinical stage I NSCLC patients treated with hypofractionated radiotherapy and reports no statistically significant differences in 2-year freedom from regional failure, DFS, or OS for EBUS-staged vs. non-EBUS staged patients. These results may point to intrinsic limitations of EBUS, competing risks to failure and cancer specific death, and effective salvage therapy in patients who recurred regionally.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vqq007
via IFTTT